We’re excited to share a fantastic LASIK event that you as our patients can attend! TLC’s Washington DC area team is hosting a free LASIK seminar with Kirk Cousins, our local quarterback and Dr. Holzman on November 15th at 6:00pm. You’ll learn about how LASIK can change your life, get your questions answered by Dr. Holzman, be entered to win raffle prizes autographed by Kirk Cousins and enjoy light refreshments. Seating is limited, so give us a call and we will reserve your spot, (703) 548-0122.
If you book LASIK at this event, you’ll also get a special $500 discount offer.
For more information, give us a call and our staff can answer all of your questions!
Eye2eye is turning 8! Help us celebrate our anniversary Monday October 17th at our Del Ray location and Wednesday October 19th from 10am-2pm.
For our patients who scheduled exams during the event, we’ll be offering complimentary makeovers ($125 value) from the celebrity makeup artist behind Phenomenal Faces, Jennifer Lee. Jennifer works with NBC Universal, she’s worked with top makeup brands like YSL and Sephora. She’ll help you refresh your look as well as help your frames work with your eye makeup.
We’ll also have two trunk shows from two of our best selling brands – Etnia at our Del Ray location and Lafont at our Hilltop location. Representatives will be on hand to style you from a wide selection of frames. We’ll have a great selection on hand of mens frames as well.
We’re also offering free non-glare lens treatment on lenses purchased during the event, this is a $169 value.
We’ll have light refreshments and birthday cake of course, so come by on Monday 10/17 or Wednesday 10/19 and help us celebrate our anniversary.
We wanted to let our patients know that Bausch + Lomb is recalling their PeroxiClear cleaning and disinfecting solution in the United States and Canada. Below we’ve shared information from Bausch + Lomb regarding the recall and specific UPC codes. If you have questions about whether or not this recall will affect you, please feel free to our offices a call and we’ll be happy to answer any questions you may have.
From Bausch + Lomb:
Bausch + Lomb is conducting a voluntary recall proposed Class II, of PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting solution in the United States and Canada. PeroxiClear is a specialty contact lens solution with a special lens case and neutralizing disc. PeroxiClear is indicated for soft and rigid gas permeable contact lenses.
Although this voluntary recall represents low risk to the consumer and is unlikely to cause serious health consequences, the company is voluntarily recalling the product from retailers, wholesalers, and eye care professionals out of an abundance of caution and as part of our ongoing commitment to quality and customer satisfaction. It is unlikely that we will be able to return the product to the marketplace within 12 months. The company chose to initiate this voluntary action based on internal testing that simulated normal product use. Testing showed occasional occurrences where the residual peroxide remaining in the lens case after neutralization was out of product specification.
PeroxiClear solution is unlikely to cause serious health consequences. If the residual hydrogen peroxide is above product specification the user of the product could experience temporary symptoms of burning/stinging, irritation, red eye and in rare circumstances other more serious health consequences.
This voluntary recall is limited to PeroxiClear only. No other Bausch + Lomb products are affected by this voluntary recall.
VOLUNTARY RECALLED PRODUCT DETAILS:
PeroxiClear 3% Hydrogen Peroxide Cleaning & Disinfecting Solution
UPC Code (USA):
UPC Code (Canada):
For more information on the voluntary product recall, please contact Stericycle, Inc., the firm conducting this product recall on behalf of Bausch + Lomb, at 1-877-877-0481. If you would like to report a product complaint, please contact the Bausch + Lomb Consumer Affairs team at 1-800-553-5340 or BLCustomerCare@bausch.com in the U.S. or 1-888-459-5000 in Canada.
Source: Eyewire Today